Obstructive sleep apnea syndrome (OSAS), commonly known as sleep apnea, can promote the development of various secondary ...

Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released its 2026 Drugs to Watch ...

Persistent exhaustion is often blamed on stress, workload, or poor sleep, but a growing body of research points to something ...

Anticipated advancements in weight loss, diabetes, oncology, rare conditions and protein degraders poised to reshape patient careLONDON, Jan. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ...

The latest update is out from Axsome Therapeutics ( (AXSM) ).

New Drug Application (NDA) submission on track for January 2026NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: ...

As of Wednesday, December 31, Axsome Therapeutics, Inc.’s AXSM share price has surged by 17.93%, which has investors ...

New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in ...

With a new year just days away, we hope the following list of the top 10 patents of 2025 sparks interest in the state of ...

From leaving your phone in another room to investing in blackout curtains and white noise machines, there’s no shortage of ...

Often undiagnosed, sleep apnea can quietly affect brain health, impacting memory, focus, and mood. A closer look at the signs ...

A good night's sleep might be an additional benefit some gain from taking weight-loss drugs like Ozempic and Zepbound, a new ...